177 related articles for article (PubMed ID: 15274680)
21. Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2008; 54(4):412-5. PubMed ID: 18645360
[TBL] [Abstract][Full Text] [Related]
22. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
23. Clinical results of treatment of postsurgical endotoxin-mediated sepsis with polymyxin-B direct hemoperfusion.
Novelli G; Ferretti G; Poli L; Pretagostini R; Ruberto F; Perrella SM; Levi Sandri GB; Morabito V; Berloco PB
Transplant Proc; 2010 May; 42(4):1021-4. PubMed ID: 20534214
[TBL] [Abstract][Full Text] [Related]
24. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
Ebihara I; Hirayama K; Kaneko S; Nagai M; Ogawa Y; Fujita S; Usui J; Mase K; Yamagata K; Kobayashi M
Ther Apher Dial; 2008 Aug; 12(4):285-91. PubMed ID: 18789115
[TBL] [Abstract][Full Text] [Related]
26. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
[TBL] [Abstract][Full Text] [Related]
27. Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
Kushi H; Miki T; Sakagami Y; Saito T; Tanjoh K
Ther Apher Dial; 2008 Aug; 12(4):292-7. PubMed ID: 18789116
[TBL] [Abstract][Full Text] [Related]
28. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
[TBL] [Abstract][Full Text] [Related]
29. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
30. Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass.
Ohki S; Oshima K; Takeyoshi I; Matsumoto K; Morishita Y
J Surg Res; 2008 Mar; 145(1):74-9. PubMed ID: 17631901
[TBL] [Abstract][Full Text] [Related]
31. Clinical Effects of Polymyxin B Hemoperfusion in Patients With Septic Shock Caused by Urinary Tract Infection.
Suzuki Y; Kojika M; Sato H; Inoue Y; Endo S
Ther Apher Dial; 2019 Feb; 23(1):80-85. PubMed ID: 30209889
[TBL] [Abstract][Full Text] [Related]
32. New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber.
Hanasawa K; Tani T; Kodama M
Surg Gynecol Obstet; 1989 Apr; 168(4):323-31. PubMed ID: 2538938
[TBL] [Abstract][Full Text] [Related]
33. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
[TBL] [Abstract][Full Text] [Related]
34. Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model.
Hussein MH; Kato T; Sugiura T; Daoud GA; Suzuki S; Fukuda S; Sobajima H; Kato I; Togari H
Pediatr Res; 2005 Aug; 58(2):309-14. PubMed ID: 16006426
[TBL] [Abstract][Full Text] [Related]
35. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
36. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
[TBL] [Abstract][Full Text] [Related]
37. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
Nakamura T; Suzuki T; Kawagoe Y; Koide H
ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
[TBL] [Abstract][Full Text] [Related]
38. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
39. Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock.
Mitaka C; Kusaoi M; Kawagoe I; Satoh D
Acute Crit Care; 2021 May; 36(2):85-91. PubMed ID: 33813808
[TBL] [Abstract][Full Text] [Related]
40. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
